Search results
Results from the WOW.Com Content Network
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. [1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, [2] to generate reports relating to the customer's ancestry and genetic ...
23andMe went public in June 2021, a few months before the Lemonaid deal closed, at $11.13 a share. Since then, 23andMe's stock price has tumbled, partly because of a massive data breach and a ...
DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company will lay off 40% of its workforce, over 200 employees, and cull its therapy ...
The 23andMe data leak was a data breach at personal genomics company 23andMe reported in October 2023. The cyberattack gathered profile and ethnicity information from millions of users. The affected customers were reported as primarily Ashkenazi Jews but also including hundreds of thousands of ethnically Chinese users. [ 1 ]
Total Health is an initiative from 23andme that is designed to provide a comprehensive look into your health, based on things like exome sequencing and biannual blood analysis. Through the service ...
23andMe said that roughly 80% of its customers consent to participate in the company's research program, which it said has generated more than 270 peer-reviewed publications uncovering new genetic ...
23andMe, born from the techno-optimism of the Human Genome Project, revolutionized direct-to-consumer genetic testing. But with its valuation now in freefall, mounting layoffs and its board ...
But on the board of directors page on 23andMe’s website, there’s now just one photo: Wojcicki, alone. Correction: This story has been updated to reflect that Steve Schoch left the company in 2022.